Memorial Day is a time to honor and remember those who have died serving our country. Each year, Eric Linthicum, 62, looks back on his…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
Dr. Melissa Johnson of the Sarah Cannon Cancer Center in Nashville, TN talks to us about a multi-center clinical trial utilizing engineered t-cell therapy similar…
Intro Dr. Patrick Forde, MD, is leading the charge in a new clinical trial investigating the effectiveness of immunotherapy in patients who are surgical candidates.…
When it comes to dealing with a mesothelioma diagnosis and its treatment, patients and their physicians are faced with many decisions. Recently, the Mesothelioma Applied…
MesoTV, the informational program by the Mesothelioma Applied Research Foundation, is now available also as a podcast. When unable to watch, patients and their families…
The International Mesothelioma Interest Group (iMig) biannual meeting kicked off in earnest today with its 2021 virtual program. The conference was initially slated to take…
The Meso Foundation announced today the addition of its new communications manager. Tobias Rodriguez has joined the organization and in this role he will work…
A phase 3 randomized clinical trial looking into the efficacy of combination chemotherapy with immunotherapy is now open in the United States and Australia. How…
The Mesothelioma Applied Research Foundation’s 2020 mesothelioma research grant cycle is now accepting pre-application letters of intent (LOI) until 11:59 PM ET Sunday, Nov. 1, 2020 on proposalCENTRAL.…
Today, the Mesothelioma Applied Research Foundation announced that it will fund three research projects in the field of mesothelioma for a total investment of $300,000…
